About ProtoKinetix
Changing lives through cell survival
Watch
ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP®, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing.
Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever.
Our vision
With AAGP®, health therapies will become more effective, more affordable and more accessible. We will get closer to cures for conditions such as Type 1 diabetes, macular degeneration, heart disease and stroke. More lives will improve, and more people will get the treatments they deserve.
Key Milestones
- 2002
Initial public offering - 2003
First intellectual property (IP) filing - 2005
Initial application for pipeline research - 2010
Good Manufacturing Practice processing and toxicology study success - 2014
IP second filing and Type 1 diabetes islet transplantation study - 2016
Preclinical validation in Type 1 diabetes and peer reviewed papers - 2016
IP third filing and induced pluripotent stem cells study for macular degeneration - 2019
Preclinical validation in macular degeneration - 2020
Engage Food and Drug Administration for consultation on Investigational Drugs and Devices approval for topical products - 2020
Large-scale bioproduct validation - 2020
First licensing agreement for topical products - 2021
Published phase one clinical results for Type 1 diabetes - 2021
Orphan disease status approval - 2021
Initiate phase one clinical trial for macular degeneration - 2022
Initiate phase two clinical trial for Type 1 diabetes - 2022
Milestone partnership agreement for biological biosimilar production
Research pipeline
We are moving cell survival forward by addressing the health conditions that affect our lives. See where we are today and where we are heading next.
Leadership team
The leaders at ProtoKinetix have a clear vision for the future of the company and for the future of regenerative medicine. Learn more about their backgrounds.
ProtoKinetix, Inc.